Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 387


Correlation between changes in global knee structures assessed on MRI and radiographic osteoarthritis changes over 10 years in a mid-life cohort.

Ijaz Khan H, Chou L, Aitken D, McBride A, Ding C, Blizzard L, Pelletier JP, Martel-Pelletier J, Cicuttini F, Jones G.

Arthritis Care Res (Hoboken). 2015 Nov 10. doi: 10.1002/acr.22778. [Epub ahead of print]


Cellular Aging, Senescence and Autophagy Processes in Osteoarthritis.

Benderdour M, Martel-Pelletier J, Pelletier JP, Kapoor M, Zunzunegui MV, Fahmi H.

Curr Aging Sci. 2015;8(2):147-57.


Impact of disease treatments on the progression of knee osteoarthritis structural changes related to meniscal extrusion: Data from the OAI progression cohort.

Roubille C, Martel-Pelletier J, Abram F, Dorais M, Delorme P, Raynauld JP, Pelletier JP.

Semin Arthritis Rheum. 2015 Dec;45(3):257-67. doi: 10.1016/j.semarthrit.2015.05.001. Epub 2015 May 15.


Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty.

Arden N, Richette P, Cooper C, Bruyère O, Abadie E, Branco J, Brandi ML, Berenbaum F, Clerc C, Dennison E, Devogelaer JP, Hochberg M, D'Hooghe P, Herrero-Beaumont G, Kanis JA, Laslop A, Leblanc V, Maggi S, Mautone G, Pelletier JP, Petit-Dop F, Reiter-Niesert S, Rizzoli R, Rovati L, Tajana Messi E, Tsouderos Y, Martel-Pelletier J, Reginster JY.

Drugs Aging. 2015 Jul;32(7):525-35. doi: 10.1007/s40266-015-0276-7.


Reply Letter to the Editor: Knee joint replacement and individual susceptibility for progression of knee osteoarthritis and tibial cartilage volume loss: not only genes run in the family.

Khan HI, Aitken D, Chou L, McBride A, Ding C, Blizzard L, Pelletier JP, Martel-Pelletier J, Cicuttini F, Jones G.

Osteoarthritis Cartilage. 2015 Oct;23(10):1819-20. doi: 10.1016/j.joca.2015.05.031. Epub 2015 Jun 4. No abstract available.


OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hand osteoarthritis.

Kloppenburg M, Maheu E, Kraus VB, Cicuttini F, Doherty M, Dreiser RL, Henrotin Y, Jiang GL, Mandl L, Martel-Pelletier J, Nelson AE, Neogi T, Pelletier JP, Punzi L, Ramonda R, Simon LS, Wang S; OARSI Hand Clinical Trial Recommendations Work Group.

Osteoarthritis Cartilage. 2015 May;23(5):772-86. doi: 10.1016/j.joca.2015.03.007. Review.


OARSI Clinical Trials Recommendations: Hand imaging in clinical trials in osteoarthritis.

Hunter DJ, Arden N, Cicuttini F, Crema MD, Dardzinski B, Duryea J, Guermazi A, Haugen IK, Kloppenburg M, Maheu E, Miller CG, Martel-Pelletier J, Ochoa-Albíztegui RE, Pelletier JP, Peterfy C, Roemer F, Gold GE.

Osteoarthritis Cartilage. 2015 May;23(5):732-46. doi: 10.1016/j.joca.2015.03.003. Review.


OARSI Clinical Trials Recommendations: Hip imaging in clinical trials in osteoarthritis.

Gold GE, Cicuttini F, Crema MD, Eckstein F, Guermazi A, Kijowski R, Link TM, Maheu E, Martel-Pelletier J, Miller CG, Pelletier JP, Peterfy CG, Potter HG, Roemer FW, Hunter DJ.

Osteoarthritis Cartilage. 2015 May;23(5):716-31. doi: 10.1016/j.joca.2015.03.004. Review.


OARSI Clinical Trials Recommendations: Knee imaging in clinical trials in osteoarthritis.

Hunter DJ, Altman RD, Cicuttini F, Crema MD, Duryea J, Eckstein F, Guermazi A, Kijowski R, Link TM, Martel-Pelletier J, Miller CG, Mosher TJ, Ochoa-Albíztegui RE, Pelletier JP, Peterfy C, Raynauld JP, Roemer FW, Totterman SM, Gold GE.

Osteoarthritis Cartilage. 2015 May;23(5):698-715. doi: 10.1016/j.joca.2015.03.012. Review.


[(18)F]-fluorodeoxyglucose positron emission tomography of the cat brain: A feasibility study to investigate osteoarthritis-associated pain.

Guillot M, Chartrand G, Chav R, Rousseau J, Beaudoin JF, Martel-Pelletier J, Pelletier JP, Lecomte R, de Guise JA, Troncy E.

Vet J. 2015 Jun;204(3):299-303. doi: 10.1016/j.tvjl.2015.03.023. Epub 2015 Mar 25.


Meniscal extrusion promotes knee osteoarthritis structural progression: protective effect of strontium ranelate treatment in a phase III clinical trial.

Roubille C, Martel-Pelletier J, Raynauld JP, Abram F, Dorais M, Delorme P, Pelletier JP.

Arthritis Res Ther. 2015 Mar 23;17:82. doi: 10.1186/s13075-015-0579-4.


Response to: 'Does it make sense to investigate whether the offspring of people with a total knee replacement for severe primary knee osteoarthritis have a higher risk of worsening knee pain?' by Lei et al.

Pan F, Ding C, Winzenberg T, Khan H, Martel-Pelletier J, Pelletier JP, Cicuttini F, Jones G.

Ann Rheum Dis. 2015 Aug;74(8):e45. doi: 10.1136/annrheumdis-2015-207620. Epub 2015 Apr 15. No abstract available.


Response to: 'Concerns about report suggesting glucosamine and chondroitin protect against cartilage loss' by Felson.

Martel-Pelletier J, Roubille C, Abram F, Hochberg M, Dorais M, Delorme P, Raynauld JP, Pelletier JP.

Ann Rheum Dis. 2015 Aug;74(8):e39. doi: 10.1136/annrheumdis-2015-207491. Epub 2015 Apr 1. No abstract available.


Magnetic Resonance Imaging-Assessed Vastus Medialis Muscle Fat Content and Risk for Knee Osteoarthritis Progression: Relevance From a Clinical Trial.

Raynauld JP, Pelletier JP, Roubille C, Dorais M, Abram F, Li W, Wang Y, Fairley J, Cicuttini FM, Martel-Pelletier J.

Arthritis Care Res (Hoboken). 2015 Oct;67(10):1406-15. doi: 10.1002/acr.22590.


Discrepancies in composition and biological effects of different formulations of chondroitin sulfate.

Martel-Pelletier J, Farran A, Montell E, Vergés J, Pelletier JP.

Molecules. 2015 Mar 6;20(3):4277-89. doi: 10.3390/molecules20034277. Review.


Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis.

Reginster JY, Cooper C, Hochberg M, Pelletier JP, Rizzoli R, Kanis J, Abadie E, Maheu E, Brandi ML, Devogelaer JP, Branco J, Herrero-Beaumont G, D'Hooghe P, Bruyère O.

Curr Med Res Opin. 2015 May;31(5):1041-5. doi: 10.1185/03007995.2015.1027183. Epub 2015 Mar 24.


Familial effects on structural changes relevant to knee osteoarthritis: a prospective cohort study.

Pan F, Khan H, Ding C, Winzenberg T, Martel-Pelletier J, Pelletier JP, Cicuttini F, Jones G.

Osteoarthritis Cartilage. 2015 Apr;23(4):559-64. doi: 10.1016/j.joca.2015.01.004. Epub 2015 Jan 13.


Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib.

Hochberg MC, Martel-Pelletier J, Monfort J, Möller I, Castillo JR, Arden N, Berenbaum F, Blanco FJ, Conaghan PG, Doménech G, Henrotin Y, Pap T, Richette P, Sawitzke A, du Souich P, Pelletier JP; on behalf of the MOVES Investigation Group.

Ann Rheum Dis. 2015 Jan 14. pii: annrheumdis-2014-206792. doi: 10.1136/annrheumdis-2014-206792. [Epub ahead of print]


PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage.

Vasheghani F, Zhang Y, Li YH, Blati M, Fahmi H, Lussier B, Roughley P, Lagares D, Endisha H, Saffar B, Lajeunesse D, Marshall WK, Rampersaud YR, Mahomed NN, Gandhi R, Pelletier JP, Martel-Pelletier J, Kapoor M.

Ann Rheum Dis. 2015 Mar;74(3):569-78. doi: 10.1136/annrheumdis-2014-205743. Epub 2015 Jan 8.


The presence of meniscal lesions is a strong predictor of neuropathic pain in symptomatic knee osteoarthritis: a cross-sectional pilot study.

Roubille C, Raynauld JP, Abram F, Paiement P, Dorais M, Delorme P, Bessette L, Beaulieu AD, Martel-Pelletier J, Pelletier JP.

Arthritis Res Ther. 2014 Dec 14;16(6):507. doi: 10.1186/s13075-014-0507-z.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk